OFTAB

This brand name is authorized in Nigeria.

Active ingredients

The drug OFTAB contains one active pharmaceutical ingredient (API):

1	Ofloxacin UNII A4P49JAZ9H - OFLOXACIN
	Ofloxacin is a quinolone-carboxylic acid derivative with a wide range of antibacterial activity against both Gram-negative and Gram-positive organisms. The primary mode of action of the quinolones is the specific inhibition of bacterial DNA gyrase. This enzyme is required for DNA replication, transcription, repair and recombination.
	Read more about Ofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-4375	Tablet	OFTAB-400 TABLETS TAB 400 mg 1X10	OFTAB-400 TABLETS OFLOXACIN USP 400MG Each Film coated tablet contains Ofloxacin USP 400 mg Excipients Lactose Starch Magnesium stearate Purified talc Colloidal anhydrous silica Cross carmellose sodium Hydroxy propyl methyl cellulose Titanium dioxide Polyethylene glycol 4000 A4-4375 Drugs Imported Products 1X10 Prescription Only Medicine (POM) 28/03/2022 FECCOX PHARMACY AND GENERAL ENTERPRISES LTD, JABA LAYOUT OFF AIRPORT RD KANO KANO 8063803298 stevefeccox2019@outlook.com SWISS PHARMA PVT . LTD., 3709, G.I.D.C., Phase IV, Vatva AHMEDABAD - 382 445, GUJARAT, INDIA., India	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA01	Ofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-4375